SCHEMBL15201248

SCHEMBL15201248

Cc1ccc(N)cc1Nc1nc(=O)cc[nH]1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 1/20 0.40
BCR P11274 1/20 0.40
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TNNI3K Q59H18 1/20 0.34
LCK P06239 1/20 0.34
ALDH1A1 P00352 4/20 0.34
CASP1 P29466 2/20 0.33
ADRA2A P08913 2/20 0.33
ADRA2C P18825 2/20 0.33
ADRA1D P25100 2/20 0.33
ADRA1A P35348 2/20 0.33
ADRA1B P35368 2/20 0.33
ELANE P08246 1/20 0.32
CYP3A4 P08684 2/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 1/20 0.32
BRPF1 P55201 1/20 0.31
RECQL P46063 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15201246 0.80 KMT2A (0.43) ABL1BCRMEN1KMT2ALCK
SCHEMBL15201255 0.80 ALDH1A1 (0.56) MEN1KMT2AALDH1A1CYP3A4TSHR
SCHEMBL15201247 0.74 KMT2A (0.68) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL15201250 0.71 ABL1 (0.45) ABL1BCRMEN1KMT2ALCK
SCHEMBL9206595 0.69 ALDH1A1 (0.37) ABL1BCRMEN1KMT2ALCK
SCHEMBL19957013 0.69
SCHEMBL22725706 0.65 GPR84 (0.37) CYP3A4
SCHEMBL26643751 0.65 GRM5 (0.41) ALDH1A1MAPK1NPC1RAB9ASMN1; SMN2
SCHEMBL24011026 0.64 RAD52 (0.55) ABL1BCRMEN1KMT2ALCK
SCHEMBL2616948 0.64 ABL1 (0.59) ABL1BCRMEN1KMT2ALCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013120852-A1 INTERMEDIATES FOR A NOVEL PROCESS OF PREPARING IMATINIB AND RELATED TYROSINE KINASE INHIBITORS GRINDEKS, A JOINT STOCK COMPANY (LV) 2013-08-22 WO claimed
WO-2013120852-A1 INTERMEDIATES FOR A NOVEL PROCESS OF PREPARING IMATINIB AND RELATED TYROSINE KINASE INHIBITORS GRINDEKS, A JOINT STOCK COMPANY (LV) 2013-08-22 WO disclosed